Adstiladrin Disease Interactions
There is 1 disease interaction with Adstiladrin (nadofaragene firadenovec).
Moderate
Nadofaragene firadenovac (applies to Adstiladrin) immunosuppression
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
Nadofaragene firadenovac is a non-replication adenoviral vector-based gene therapy. Patients who are immunocompromised or immunodeficient may be at risk for disseminated adenovirus infection. Avoid exposure to this drug in those patients.
Switch to professional interaction data
Adstiladrin drug interactions
There are 314 drug interactions with Adstiladrin (nadofaragene firadenovec).
Report options
QR code containing a link to this page
More about Adstiladrin (nadofaragene firadenovec)
- Adstiladrin consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
